跳至主要内容
临床试验/NCT01739686
NCT01739686已完成不适用

Collaborative Care to Alleviate Symptoms and Adjust to Illness in Chronic Heart Failure (CASA) Trial

Denver Research Institute6 个研究点 分布在 1 个国家目标入组 317 人开始时间: 2012年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
317
试验地点
6
主要终点
Difference in Kansas City Cardiomyopathy Questionnaire (KCCQ) overall score

研究概览

简要总结

Chronic heart failure is an important public health problem as it is a leading cause of disability, hospitalization, death, and costs. People who live with advanced chronic heart failure suffer from numerous symptoms that affect their daily lives. The investigators are conducting a randomized clinical trial to evaluate a symptom management and psychosocial care intervention to improve health status (symptom burden, functioning, and quality of life). The results will be directly relevant to patients and families who suffer with this illness, as well as to providers, payers, and other researchers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years of age or older
  • Able to read and understand English
  • Consistent access to a telephone
  • Patients have a primary care or other provider who is willing to facilitate intervention medical recommendations
  • A diagnosis of heart failure with at least one of the following:
  • [hospitalization primarily for heart failure in the year prior (including current); taking at least 20 mg oral furosemide (or equivalent) daily in a single or divided dose; Brain natriuretic peptide(BNP) ≥ 100 or N-terminal prohormone of brain natriuretic peptide(NT-proBNP) ≥ 500; EF≤40%]
  • Report a low health status (KCCQ-SF≤70)
  • Bothered by at least one target symptom:
  • [Pain; Depression; Fatigue; Breathlessness]

排除标准

  • Previous diagnosis of dementia
  • Active substance abuse or dependence, defined by either a diagnosis of abuse or dependence or an AUDIT-C ≥ 8, or self-reported substance abuse in the past 3 months
  • Comorbid metastatic cancer
  • Nursing home resident
  • Heart Transplant recipient
  • LVAD recipient

研究组 & 干预措施

CASA Intervention

Experimental

The CASA (Collaborative Care to Alleviate Symptoms and Adjust to Illness) intervention includes 3 components:

  • A nurse (RN) follows structured algorithms to help patients with symptoms, specifically breathlessness, fatigue, pain, and depression.
  • A social worker provides structured counseling targeting adjustment to illness and depression if present.
  • A collaborative care model of care delivery, in which the nurse and social worker meet weekly with a primary care provider, cardiologist and palliative care specialist. This team makes medical recommendations to the intervention subjects' providers and supervises the nurse and social worker.

Most of the nurse and social worker visits are by phone.

干预措施: CASA Intervention (Other)

Usual Care

No Intervention

Patients in the control group will continue to receive care at the discretion of their providers, which may include referral to cardiology, palliative care, or mental health. If patients self-report depression on baseline surveys, this information will be given to their provider, and patients will be given resources. Patients will have the same amount of interaction with research assistants as the intervention patients, completing questionnaires and participating in study visits at the same frequency.

结局指标

主要结局

Difference in Kansas City Cardiomyopathy Questionnaire (KCCQ) overall score

时间窗: 6 months

The KCCQ is a self-administered questionnaire that measures heart failure-specific health status. The KCCQ is reliable, sensitive to clinical change, and predicts hospitalization and mortality. The study will test whether there is a difference in KCCQ overall score between the intervention and control groups at 6 months.

次要结局

  • Difference in pain using the PEG(6 months)
  • Difference in Patient Health Questionnaire-9 (PHQ-9) score(6 months)
  • Difference in Satisfaction with Healthcare(6 months)
  • Change in Dyspnea(6 months)
  • Difference in symptom distress, measured using the General Symptom Distress Scale(6 months)
  • Difference in Self-care of Heart Failure Index (SCHFI)(12 months)
  • Change in Sheehan Disability Scale(12 months)
  • Change in Quality of Life at the End of Life (QUAL-E)(12 months)
  • Change in fatigue using the Patient Reported Outcomes Measurement Information System (PROMIS) fatigue measure(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Bekelman, M.D.

Associate Professor of Medicine

Denver Research Institute

研究点 (6)

Loading locations...

相似试验